MS in the QC Lab
This Monday morning session explores the various issues that arise in the quality control laboratory. Jason Rouse of Phizer, Inc. will chair the session, which will be held in Ballroom 20 BC on the upper level, from 8:30 to 10:30 pm.
This Monday morning session explores the various issues that arise in the quality control laboratory. Jason Rouse of Phizer, Inc. will chair the session, which will be held in Ballroom 20 BC on the upper level, from 8:30 to 10:30 pm.
Richard Rogers of Just Biotherapeutics in Seattle, Washington, will give the first talk, “Improving Critical Quality Attribute Coverage and MAM Thoughput by Leveraging a Multi-Enzyme Multi-Attribute Method.” He will present a 4X improvement in the throughput of Multi-Attribute Method (MAM) by leveraging a dual column UPLC and Multi-Enzyme MAM.
Next, Jason L. Richardson of Amgen will present “Unattended Just-In-Time Antibody Digestion and Analysis on a Regular LC/MS System Without Additional Equipment.” His talk will examine a new method that is suitable for protein structural characterization, quality attributes analysis, and peptide-based MAM.
Following Richardson, John Scheil of NIST give a talk titled “Mass Spectrometry-Based Characterization of a Non-Originator NISTmAb.” Extended characterization data from the NISTmAb in comparison to a non-originator NISTmAb will be presented to highlight the complexity of historical knowledge space generation.
Sarah Rogstad of the Food and Drug Administration will be the next speaker, presenting “Development and Assessment of the Multi-Attribute Method (MAM): New Peak Detection and Orthogonal Method Comparisons.” The study addresses certain considerations to better assess the applicability of method.
Robert Birdsall of Waters Corporation will follow Rogstad with a presentation titled “Streamlining the Identification and Monitoring of Product and Process Attributes in Biopharmaceutical Development and QC with MAM-based Workflows.” The study generated a data set representative of a process development setting to demonstrate how these challenges can be addressed with a single CDS platform with MS control and data processing capabilities.
The final presentation will be from Phillip Anderson of Avista Pharma Solution. Anderson’s talk is titled “ID Testing by HRMS of Large-Molecule Biological Reagents for GMP Manufacturing.” This study determined that electrospray ionization high-resolution mass spectrometry is well-suited for specific and reproducible methods for the identification of biological reagents.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
